Skip to content

Columns
- Just Breathe
- Younger than 30
What is PF?
- Causes
- Types
- Stages
- Genetics
- Prevention
- Pulmonary Fibrosis and PAH
- Diagnosis
- Prognosis
Symptoms
Treatment
Therapies
- Approved IPF Therapies
  - Ofev (nintedanib)
  - Esbriet (pirfenidone)
- Experimental IPF Therapies
Ofev
Esbriet
Clinical Trials
- About Clinical Trials
- PF Clinical Trial
News Categories
- IPF
- PF Foundation
- FDA
- OFEV
- ESBRIET
Social Clips

Search for:

News

May 19, 2015July 26, 2016

by admin

Home » News

Get Our Free PF Email Newsletter

* indicates required

Email Address *

First Name

Last Name

Context Partners with Research Institutions to Study Sigma1 Protein in Treatment of Fibrosis, Cancer

August 21, 2017
Constant Fatigue and Its Emotional Toll

August 21, 2017
12 Facts About Pulmonary Fibrosis Prognosis and Life Expectancy

August 21, 2017
Prometic to Advance IPF and Other Anti-fibrotic Therapies in Clinical Testing via Partnership in China

August 18, 2017
Video Guide to Creating a Chronic Illness Survival Pack

August 18, 2017

Pulmonary Fibrosis News

BioNews Services, LLC
5307 E. Mockingbird Ln.
5th Floor
Dallas, TX 75206
Email: info@bionewsservices.com
Phone: 1-800-936-1363

Disclaimer:

Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Leave a Comment Cancel reply